Diabetology & Metabolic Syndrome

OCT 15, 2026 · JOURNAL ARTICLE

Circulating miRNA signatures reveal metabolic dysfunction beyond obesity

Diabetology & Metabolic Syndrome

To identify circulating microRNA (miRNA) signatures associated with metabolic health status independent of body mass index (BMI) and to characterize their underlying regulatory pat

OCT 14, 2026 · JOURNAL ARTICLE

Integrative multi-omics mendelian randomization identifies suggestive glycolytic candidates associated with insulin resistance in obesity: a discovery-based study

Diabetology & Metabolic Syndrome

Metabolically unhealthy obesity (MUO) is characterized by adipose tissue dysfunction and insulin resistance (IR), though the causal genetic drivers remain elusive. We applied multi

OCT 8, 2026 · JOURNAL ARTICLE

Tracking the obesity epidemic: a comprehensive population-based epidemiological assessment of obesity prevalence and its cardiovascular-kidney-metabolic complications

Diabetology & Metabolic Syndrome

Excess adiposity is increasingly prevalent worldwide and is associated with substantial cardiovascular-kidney–metabolic (CKM) morbidity. This study aimed to quantify the prevalence

SEP 10, 2026 · JOURNAL ARTICLE

Measures of obesity and first atherosclerotic cardiovascular events in stage 0 cardiovascular-kidney-metabolic syndrome: Tehran lipid and glucose study

Diabetology & Metabolic Syndrome

Prospective cohort study with 19.6-year median follow-up, hard clinical endpoint (incident ASCVD), and consistent dose–response relationships across multiple abdominal obesity measures with statistical significance and robust sensitivity analyses.

SEP 10, 2026 · JOURNAL ARTICLE

Microbiota-targeted interventions for metabolic syndrome-related parameters in adolescents with overweight or obesity: a systematic review and meta-analysis

Diabetology & Metabolic Syndrome

A rigorous systematic review and meta-analysis of 16 RCTs confirms that microbiota-targeted interventions do not substantially improve metabolic syndrome parameters in adolescents with obesity, reinforcing the current evidence of limited efficacy.

AUG 14, 2026 · JOURNAL ARTICLE

Risk factors for metabolic syndrome: an umbrella review of systematic reviews and meta-analyses

Diabetology & Metabolic Syndrome

A systematic umbrella review of 72 meta-analyses synthesizing evidence from 7,367 articles on 101 risk factors for metabolic syndrome, providing comprehensive pooled estimates with confidence intervals and heterogeneity assessment.

AUG 10, 2026 · JOURNAL ARTICLE

Association of glucagon-like peptide-1 receptor agonist therapy with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

Diabetology & Metabolic Syndrome

Meta-analysis of six observational cohort studies showing a statistically significant 26% lower hazard of AF recurrence with GLP-1RA therapy, but low certainty of evidence and lack of randomized data limit strength.

AUG 6, 2026 · JOURNAL ARTICLE

Endocrine and metabolic profiling of PMOS rat models in relation to clinical obese and non-obese phenotypes

Diabetology & Metabolic Syndrome

Systematic comparison of three rat models against clinical PMOS features, but uncontrolled animal work with small per-group samples (n=8) and no between-model statistical testing reported; provides descriptive phenotypic characterization to guide model selection rather than a testable clinical or mechanistic finding.